CS
GH icon

Credit Suisse’s Guardant Health GH Stock Holding History

Credit Suisse’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$38.1M Buy
1,844,796
+88,461
+5% +$1.9M 0.04% 444
2023
Q4 		$47.5M Buy
1,756,335
+39,827
+2% +$1.04M 0.05% 403
2023
Q3 		$50.9M Sell
1,716,508
-475,213
-22% -$16.7M 0.05% 368
2023
Q2 		$78.5M Buy
2,191,721
+43,850
+2% +$1.26M 0.08% 262
2023
Q1 		$50.3M Buy
2,147,871
+36,828
+2% +$1.05M 0.05% 398
2022
Q4 		$57.4M Buy
2,111,043
+301,890
+17% +$13.8M 0.06% 345
2022
Q3 		$97.4M Sell
1,809,153
-625
-0% -$32.1K 0.11% 193
2022
Q2 		$73M Sell
1,809,778
-8,165
-0.4% -$405K 0.08% 274
2022
Q1 		$120M Buy
1,817,943
+7,922
+0.4% +$542K 0.1% 208
2021
Q4 		$181M Buy
1,810,021
+19,946
+1% +$2.06M 0.1% 203
2021
Q3 		$224M Buy
1,790,075
+4,317
+0.2% +$513K 0.12% 148
2021
Q2 		$222M Buy
1,785,758
+32,313
+2% +$4.35M 0.12% 174
2021
Q1 		$268M Buy
1,753,445
+113,127
+7% +$17.1M 0.14% 137
2020
Q4 		$211M Buy
1,640,318
+157,003
+11% +$18.1M 0.1% 202
2020
Q3 		$166M Buy
1,483,315
+82,954
+6% +$7.59M 0.1% 206
2020
Q2 		$114M Buy
1,400,361
+549,597
+65% +$44.3M 0.08% 248
2020
Q1 		$59.2M Buy
850,764
+96,710
+13% +$7.42M 0.05% 374
2019
Q4 		$58.9M Buy
754,054
+178,873
+31% +$12.9M 0.04% 459
2019
Q3 		$36.7M Buy
575,181
+58,945
+11% +$5.19M 0.03% 601
2019
Q2 		$44.6M Buy
516,236
+82,197
+19% +$6.28M 0.04% 493
2019
Q1 		$33.3M Sell
434,039
-8,416
-2% -$467K 0.03% 597
2018
Q4 		$16.6M Buy
+442,455
New +$16.3M 0.02% 889

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse's GH Position: Q1 2024 in Review

Credit Suisse increased its Guardant Health (GH) stake by 5% in Q1 2024, buying an estimated $1.9M and bringing the position to 1,844,796 shares worth $38.1M. The position accounts for 0.04% of the portfolio, ranked #444.

Credit Suisse first reported a position in GH in Q4 2018 and has held it in 22 quarters since. The position peaked at $268M in Q1 2021. 257 funds tracked by Wall St. Rank hold GH as of Q1 2024.

  • Credit Suisse held 1,844,796 shares of Guardant Health worth $38.1M as of Q1 2024.
  • Credit Suisse bought 88,461 Guardant Health shares in Q1 2024, an estimated $1.9M.
  • Guardant Health made up 0.04% of Credit Suisse's portfolio in Q1 2024, its #444 holding.
  • Credit Suisse first reported a position in Guardant Health in Q4 2018 and has held it in 22 quarters since.
  • Credit Suisse's Guardant Health position peaked at $268M in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.